CLINICAL_TRIALS
trial_result
· 2019-08-28
Clinical Trial Update: The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer [Phase 1, Phase 2]
Summary
Clinical trial update on allogenic platelet-rich plasma for diabetic foot ulcer across Phase 1 and Phase 2.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hanan Jafar | Conditions: Diabetic Foot Ulcer | Phase 1, Phase 2 | Status: UNKNOWN